NIMGenetics

NIMGenetics

Innovamos en medicina pensando en ti

Founded 2008 Spain

Spain 89 employees Venture round Total: $7.00M Biotechnology, Health Care

NIMGenetics is a Spanish biotechnology and healthcare company, founded in 2007, that operates as an analytical diagnostic center with a genetics unit authorized by the Health Department of the Community of Madrid. The company's accredited scientific and medical team is specialized in high-resolution genomic systems, aiming to provide reliable and precise clinical diagnosis. One of NIMGenetics' main objectives is to efficiently provide medical professionals with the latest scientific advances in genomic tools, such as CGH arrays, to enhance healthcare in terms of prevention, prognostic characterization, and diagnostic reliability. Additionally, the company offers personalized services to researchers and research institutions, including the design and selection of suitable platforms and comprehensive bioinformatic analysis. Since 2008, NIMGenetics has been backed by the CDTI, enhancing its innovation capabilities. The company has developed and validated various genomic analysis platforms with clinical applicability, such as KaryoNIM®, which facilitates the identification of DNA copy number alterations with phenotypic repercussions. In 2009, NIMGenetics was accredited by the Health Department of the Community of Madrid as an Analytical Diagnostic Center with a Genetics Unit. Currently, over 50 diagnostic centers, clinics, and hospitals utilize NIMGenetics' services. In May 2017, the company received a significant €7.00M Venture Round investment led by Apposite Capital. This investment has further bolstered NIMGenetics' position in the biotechnology and healthcare space, potentially paving the way for continued growth and innovation in the company's offerings.

Funding Stage	Amount	Investors	Lead Investors	Date
Venture Round	€7.00M	1	Apposite Capital	10 May 2017

Funding Stage

Amount

Investors

Lead Investors

Date

Venture Round

€7.00M

Apposite Capital

10 May 2017

FAQ About NIMGenetics

Innovamos en medicina pensando en ti

NIMGenetics was founded in 2008.

NIMGenetics is headquartered in Spain.

NIMGenetics operates in Biotechnology and Health Care. Its work centres on genetics, diagnostic analysis, medical innovation and genomic tools.

NIMGenetics has approximately 89 employees.

NIMGenetics has completed 1 funding round, raising a total of $7.00M. The latest funding stage is Venture round.

Top alternatives and competitors to NIMGenetics include Mendelics, 广州嘉检医学检测有限公司, NalaGenetics, Genomics, SkylineDx BV. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

NIMGenetics and Mendelics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About NIMGenetics

Funding Rounds & Investors (1)

NIMGenetics Alternatives & Competitors

FAQ About NIMGenetics